Wellinks Recognized as Quarterfinalist for the Digital Health Hub Foundation: Digital Health Awards

Amy Johnston
September 4, 2024
Table of Contents

NEW HAVEN, Conn., Sept. 4, 2024 (GLOBE NEWSWIRE) — Wellinks, is thrilled to announce its selection as a quarterfinalist for the prestigious 2024 Digital Health Hub Foundation: Digital Health Awards. Wellinks was chosen as a quarterfinalist for the Rising Star - Home Health Diagnostic award. 

This recognition highlights the company's dedication to innovation and excellence in pulmonary health. The Digital Health Awards celebrate organizations that demonstrate excellence in leveraging digital advancements to enhance healthcare services and patient outcomes. As a quarterfinalist, Wellinks stands out for its commitment to enhancing virtual care for those with chronic respiratory disease, so they achieve healthier lives.

This recognition highlights Wellinks for its significant contributions to advancing the management of chronic pulmonary disease and empowering people to live fully and breathe freely. The Digital Health Hub Foundation Awards honor organizations making strides in improving healthcare speed, efficiency and equity with their digital innovations. Being named a quarterfinalist reflects Wellinks commitment to driving meaningful change in the healthcare landscape.

“Here at Wellinks we’re breaking the access issues to bring virtual care into the home so we can provide interventions and change the course of disease for these patients,” said Dr. Abi Sunddaramoorthy,  Chief Medical Officer at Wellinks.

Out of a substantial pool of over 1,500 submissions, only the most promising 16 quarterfinalists per category, per track have advanced to this stage. 

"This year has set a new benchmark for excellence, with a remarkable influx of global submissions showcasing groundbreaking innovations in digital health. The level of ingenuity and commitment we’ve seen is truly inspiring. Congratulations to all our quarterfinalists for their outstanding achievements," said Mark Goldstein, Chairman of the Digital Health Hub Foundation.

Finalists will be announced September 22, 2023, and the winners will be announced at the Grand Finale taking place at HLTH on October 21, 2024. 

 

About Digital Health Hub Foundation:

Our mission is to help the world’s next best innovative healthcare companies scale and grow. Founded in 2017, on the campus of UCSF in San Francisco, our now 30,000 member community consists of thousands of early-to late-stage healthcare companies and highly qualified healthcare industry providers, payors, experts, mentors, investors, clinicians and researchers who participate in our annual awards ceremony where we bring together the industry to honor and validate the best of the best and celebrate the technological advances in healthcare and the impact it has.

 

About Wellinks

Wellinks is on a mission to help those with chronic obstructive pulmonary disease (COPD) live fully and breathe freely. COPD is the third leading cause of death by chronic disease in the U.S. and the fifth most costly chronic disease. With its personalized, virtual-first COPD management system, Wellinks breaks down barriers for patients, providing the evidence-based care they need and deserve outside the four walls of the clinic. Wellinks supports patients through virtual pulmonary rehabilitation, health coaching, and monitoring through connected devices and an easy-to-use smartphone app. Based in New Haven, Connecticut, Wellinks is led by a team of digital health veterans and backed by top investment firms including Morningside, HighCape Capital, Connecticut Innovations, and Benslie. For more information, visit www.wellinks.com and follow on Twitter (@WellinksHealth) and LinkedIn.

Press Contact:

Amy Johnston

[email protected]

NEW HAVEN, Conn., Sept. 4, 2024 (GLOBE NEWSWIRE) — Wellinks, is thrilled to announce its selection as a quarterfinalist for the prestigious 2024 Digital Health Hub Foundation: Digital Health Awards. Wellinks was chosen as a quarterfinalist for the Rising Star - Home Health Diagnostic award. 

This recognition highlights the company's dedication to innovation and excellence in pulmonary health. The Digital Health Awards celebrate organizations that demonstrate excellence in leveraging digital advancements to enhance healthcare services and patient outcomes. As a quarterfinalist, Wellinks stands out for its commitment to enhancing virtual care for those with chronic respiratory disease, so they achieve healthier lives.

This recognition highlights Wellinks for its significant contributions to advancing the management of chronic pulmonary disease and empowering people to live fully and breathe freely. The Digital Health Hub Foundation Awards honor organizations making strides in improving healthcare speed, efficiency and equity with their digital innovations. Being named a quarterfinalist reflects Wellinks commitment to driving meaningful change in the healthcare landscape.

“Here at Wellinks we’re breaking the access issues to bring virtual care into the home so we can provide interventions and change the course of disease for these patients,” said Dr. Abi Sunddaramoorthy,  Chief Medical Officer at Wellinks.

Out of a substantial pool of over 1,500 submissions, only the most promising 16 quarterfinalists per category, per track have advanced to this stage. 

"This year has set a new benchmark for excellence, with a remarkable influx of global submissions showcasing groundbreaking innovations in digital health. The level of ingenuity and commitment we’ve seen is truly inspiring. Congratulations to all our quarterfinalists for their outstanding achievements," said Mark Goldstein, Chairman of the Digital Health Hub Foundation.

Finalists will be announced September 22, 2023, and the winners will be announced at the Grand Finale taking place at HLTH on October 21, 2024. 

 

About Digital Health Hub Foundation:

Our mission is to help the world’s next best innovative healthcare companies scale and grow. Founded in 2017, on the campus of UCSF in San Francisco, our now 30,000 member community consists of thousands of early-to late-stage healthcare companies and highly qualified healthcare industry providers, payors, experts, mentors, investors, clinicians and researchers who participate in our annual awards ceremony where we bring together the industry to honor and validate the best of the best and celebrate the technological advances in healthcare and the impact it has.

 

About Wellinks

Wellinks is on a mission to help those with chronic obstructive pulmonary disease (COPD) live fully and breathe freely. COPD is the third leading cause of death by chronic disease in the U.S. and the fifth most costly chronic disease. With its personalized, virtual-first COPD management system, Wellinks breaks down barriers for patients, providing the evidence-based care they need and deserve outside the four walls of the clinic. Wellinks supports patients through virtual pulmonary rehabilitation, health coaching, and monitoring through connected devices and an easy-to-use smartphone app. Based in New Haven, Connecticut, Wellinks is led by a team of digital health veterans and backed by top investment firms including Morningside, HighCape Capital, Connecticut Innovations, and Benslie. For more information, visit www.wellinks.com and follow on Twitter (@WellinksHealth) and LinkedIn.

Press Contact:

Amy Johnston

[email protected]

Driving Better Outcomes
COPD foundation logo and Wellinks logo - Wellinks Images

Wellinks is excited to announce the final results of ASPIRE – a clinical trial conducted with the COPD Foundation to assess the impact of Wellinks on quality of life, engagement and satisfaction among COPDF members living with COPD.

Circle with 3 images- laptop, smartphone and call screenshot - Wellinks Images
Each participant received personalized health coaching, virtual pulmonary rehabilitation, and monitoring through connected devices and a patient-facing app.

The study enrolled 141 members in the trial, with 119 completing the 24-week study. These results demonstrate sustained engagement, satisfaction, and clinical response with Wellinks.

Interested in learning more about Wellinks?

Request a Demo Today

Wellinks Engagement at 24 Weeks
(n = 141)

61%
Finger pressing the "Join" button - Wellinks Images
Enrollment Rate

Proportion successfully enrolled out of all who were interested and eligible

84%
Two hands shaking - Wellinks Images
Retention Rate

Proportion who remained enrolled in the study at 24 weeks

These results were demonstrated in a population with...

Web stats - Wellinks Images

High Member Satisfaction at 24 Weeks

  • Over 81% said Wellinks helped them better manage their COPD
  • Over 92% found Wellinks to be valuable
  • Over 83% said Wellinks helped them learn more about their COPD
+64
Net Promoter Score*
* Net Promoter Score (NPS) is a customer loyalty and satisfaction measurement taken from asking customers how likely they are to recommend your product. NPS scores range from -100 to +100. This NPS is based on responses from those who continued contact with coaches, representative of the Wellinks clinical model.

Improved Clinical Outcomes at 24 Weeks

Healthcare icon - Wellinks Images
Wellinks demonstrated sustained improvements in COPD self-efficacy as measured by the COPD Self-efficacy Scale (CSES) at 24 weeks.
Respiratory icon - Wellinks Images
Self-efficacy is a measure of how confident an individual is in managing their COPD and addressing shortness of breath.
Magnifying glass icon - Wellinks Images

One-third of participants demonstrated improvements in Modified Medical Research Council dyspnea score. mMRC is a measure of breathlessness that is associated with risk of future exacerbations.

Sign up to stay updated on ASPIRE and Wellinks.

Thank you! Stay tuned for more Wellinks news soon.

Oops! Something went wrong while submitting the form.
*By providing your email address, you agree to opt into receiving our Wellinks marketing emails.
You can unsubscribe at any time. Your information will be held confidential.